We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00112554
Recruitment Status : Completed
First Posted : June 3, 2005
Last Update Posted : November 6, 2013
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2008
  Study Completion Date : March 2008